Justin Dye - Nov 14, 2022 Form 4 Insider Report for Medicine Man Technologies, Inc. (SHWZ)

Role
CEO, Director, 10%+ Owner
Signature
/s/ Daniel R. Pabon, Attorney-in-Fact for Justin Dye
Stock symbol
SHWZ
Transactions as of
Nov 14, 2022
Transactions value $
$672,408
Form type
4
Date filed
11/16/2022, 07:56 PM
Previous filing
Apr 8, 2022
Next filing
Nov 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SHWZ Common Stock Award $186K +142K +95.66% $1.31 291K Nov 14, 2022 Direct F1
transaction SHWZ Common Stock Award $294K +187K +64.43% $1.57 478K Nov 15, 2022 Direct F2
transaction SHWZ Common Stock Award $192K +107K +22.26% $1.80 585K Nov 16, 2022 Direct F3
holding SHWZ Common Stock 9.29M Nov 14, 2022 See footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.13 to $1.43 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.34 to $1.74 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F3 The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.68 to $1.86 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F4 Represents shares of common stock held by Dye Capital & Company, LLC ("Dye Capital"). As the general partner of Dye Capital, Mr. Dye has voting and investment control over the securities held by Dye Capital. Mr. Dye disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.